Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
BNF presentation directory
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Fiery Jack 2.466% ointment
1003020H0BCAAAH
|
Fiery Jack (Ointment) | Capsicum | Musculoskeletal and Joint Diseases | No data available |
|
Fiery Jack cream
1003020T0BJAAA0
|
Fiery Jack (Cream) | Nicotinates | Musculoskeletal and Joint Diseases | No data available |
|
Filgotinib 100mg tablets
1001030AGAAAAAA
|
Filgotinib | Filgotinib | Musculoskeletal and Joint Diseases | No data available |
|
Filgotinib 200mg tablets
1001030AGAAABAB
|
Filgotinib | Filgotinib | Musculoskeletal and Joint Diseases | No data available |
|
Firdapse 10mg tablets
100201000BNAVAD
|
Proprietary compound preparation BNF 1002010 | Other neuromuscularar transmisson preparations | Musculoskeletal and Joint Diseases | No data available |
|
First Resort Double Action Pain Relief 12.5mg tablets
1001010AGBEABAC
|
First Resort Double Action Pain Relief | Diclofenac potassium | Musculoskeletal and Joint Diseases | No data available |
|
First Resort Period Pain Reliever 250mg gastro-resistant tab
1001010P0BVAAAH
|
First Resort Period Pain Reliever | Naproxen | Musculoskeletal and Joint Diseases | No data available |
|
Flamatak MR 100mg tablets
1001010C0BYAAAF
|
Flamatak | Diclofenac sodium | Musculoskeletal and Joint Diseases | No data available |
|
Flamatak MR 75mg tablets
1001010C0BYABAL
|
Flamatak | Diclofenac sodium | Musculoskeletal and Joint Diseases | No data available |
|
Flamrase 25 EC tablets
1001010C0BKAAAD
|
Flamrase | Diclofenac sodium | Musculoskeletal and Joint Diseases | No data available |
|
Flamrase 50 EC tablets
1001010C0BKABAE
|
Flamrase | Diclofenac sodium | Musculoskeletal and Joint Diseases | No data available |
|
Flamrase 75mg SR tablets
1001010C0BKADAL
|
Flamrase | Diclofenac sodium | Musculoskeletal and Joint Diseases | No data available |
|
Flamrase SR 100mg tablets
1001010C0BKACAF
|
Flamrase | Diclofenac sodium | Musculoskeletal and Joint Diseases | No data available |
|
Flarin Joint & Muscular Pain Relief 200mg capsules
1001010J0DIABAA
|
Flarin | Ibuprofen | Musculoskeletal and Joint Diseases | No data available |
|
Flexeze capsules
1001050A0CEAAAQ
|
Flexeze (Glucosamine hydrochloride) | Glucosamine hydrochloride (Rheumatic) | Musculoskeletal and Joint Diseases | No data available |
|
Flexi-melt Glucosamine hydrochloride 750mg tablets
1001050A0BGAAAE
|
Flexi-melt | Glucosamine hydrochloride (Rheumatic) | Musculoskeletal and Joint Diseases | No data available |
|
Flexin-25 Continus tablets
1001010K0BNACAL
|
Flexin Continus | Indometacin | Musculoskeletal and Joint Diseases | No data available |
|
Flexin-50 Continus tablets
1001010K0BNABAK
|
Flexin Continus | Indometacin | Musculoskeletal and Joint Diseases | No data available |
|
Flexin-75 Continus tablets
1001010K0BNAAAJ
|
Flexin Continus | Indometacin | Musculoskeletal and Joint Diseases | No data available |
|
Flexotard MR 100mg tablets
1001010C0BXAAAF
|
Flexotard | Diclofenac sodium | Musculoskeletal and Joint Diseases | No data available |
|
Flixabi 100mg pdr for concentrate for inf vials
1001030T0BEAAAA
|
Flixabi | Infliximab | Musculoskeletal and Joint Diseases | No data available |
|
Flurbiprofen 100mg suppositories
1001010I0AAAAAA
|
Flurbiprofen (NSAID) | Flurbiprofen | Musculoskeletal and Joint Diseases | No data available |
|
Flurbiprofen 200mg modified-release capsules
1001010I0AAADAD
|
Flurbiprofen (NSAID) | Flurbiprofen | Musculoskeletal and Joint Diseases | No data available |
|
Fosachew 1500mg chewable tablets
1001050A0BUAAAC
|
Fosachew | Glucosamine hydrochloride (Rheumatic) | Musculoskeletal and Joint Diseases | No data available |
|
Fosachew 500mg/400mg chewable tablets
1001050A0BUABAD
|
Fosachew | Glucosamine hydrochloride (Rheumatic) | Musculoskeletal and Joint Diseases | No data available |
Why monitor BNF codes?
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Understand demand drivers
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.